Effects of certain iron-chelators and antibiotics on the interaction of succinate dehydrogenase and cytochrome b in ubiquinone-depleted submitochondrial particles.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002074:Butanones / Q000494:pharmacology*; D002417:Cattle; D002614:Chelating Agents / Q000494:pharmacology*; D003580:Cytochromes / Q000378:metabolism*; D004492:Edetic Acid / Q000494:pharmacology; D004789:Enzyme Activation; D005461:Fluorine / Q000494:pharmacology; D066298:In Vitro Techniques; D008566:Membranes / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D008931:Mitochondria, Muscle / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D009206:Myocardium; D009711:Nucleotides / Q000494:pharmacology; D009840:Oligomycins / Q000494:pharmacology; D010101:Oxygen Consumption; D013385:Succinate Dehydrogenase / Q000037:antagonists & inhibitors; D013386:Succinates / Q000494:pharmacology; D013876:Thiophenes / Q000494:pharmacology*; D014451:Ubiquinone / Q000502:physiology; D014634:Valinomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D002074:Butanones; D002614:Chelating Agents; D003580:Cytochromes; D009711:Nucleotides; D009840:Oligomycins; D013386:Succinates; D013876:Thiophenes; D014451:Ubiquinone; D014634:Valinomycin; D005461:Fluorine; D004492:Edetic Acid; D013385:Succinate Dehydrogenase